ColombiaTaevas Global helps medical devices manufacturers achieve INVIMA registration and enter the Colombian market with confidence, speed, and full regulatory compliance. From classification to approval, we manage every step so you can focus on growth.
Our six interconnected pillars cover every dimension of the INVIMA registration journey, from regulatory strategy through post-market surveillance, giving medical devices companies a complete foundation for successful Colombia market entry.
We analyze your device against Colombia's Decree 4725 of 2005 and INVIMA's risk classification framework to determine the correct risk class — I, IIA, IIB, or III — and the appropriate registration pathway. Accurate classification from the outset prevents costly rework and delays. Our team maps international equivalencies including FDA 510(k) and CE Mark to accelerate the technical file preparation.
Our four-phase engagement moves your medical device from initial scoping through INVIMA submission and beyond, delivering clear milestones and actionable outputs at every stage.
We begin with a structured intake session to understand your device, its intended use, existing international approvals, and your commercial timeline. Our regulatory team performs an initial classification review under Decree 4725 and identifies the correct registration pathway. You receive a scoping memo outlining the registration route, estimated timeline, and document requirements within 72 hours.
The scoping memo includes a checklist of required technical documents, an assessment of whether existing FDA or CE Mark documentation can be leveraged, identification of any mandatory in-country testing requirements, and a preliminary timeline with key milestones. This document becomes the project charter for the entire engagement.
Colombia is the third-largest medical devices market in Latin America and the largest in the Andean Community, driven by a population of over 51 million and a rapidly expanding middle class with growing healthcare demand. Public healthcare spending has increased steadily following reforms to the General System of Social Security in Health, creating significant procurement opportunities for registered device manufacturers.
INVIMA has invested substantially in its SIREM digital submission platform and streamlined its technical review processes for medical devices, reducing administrative bottlenecks for well-prepared dossiers. The regulator has also issued updated guidance aligning Colombian requirements more closely with IMDRF frameworks, which benefits manufacturers holding FDA clearance or CE Mark by enabling greater document reuse.
Colombia imports approximately 85 percent of its medical devices, primarily from the United States, Germany, and China, meaning the market is structurally open to international manufacturers. The absence of significant domestic manufacturing competition in most device categories means that foreign companies with INVIMA registration can capture market share relatively quickly through established distributor networks.
Demand for diagnostic imaging equipment, minimally invasive surgical devices, point-of-care diagnostics, and digital health technologies is growing faster than the overall market, fueled by hospital infrastructure investment in major cities including Bogota, Medellin, Cali, and Barranquilla. INVIMA has developed specific guidance for software as a medical device (SaMD), creating a defined pathway for digital health product registration.
Every Taevas Global Product Registration engagement for Colombia delivers a structured set of outputs that take your device from regulatory scoping to approved market access, with full documentation at each stage.
A formal written assessment of your device's risk class under Decree 4725, including the applicable registration pathway, fee schedule, and timeline estimate. The report includes a comparison with your existing international classifications to identify documentation leverage opportunities.
A fully compiled, Spanish-language technical dossier meeting all INVIMA content requirements for your device's risk class, including device description, intended use, clinical evidence summary, risk management overview, and quality system documentation.
A structured review of your existing technical documentation against INVIMA requirements, identifying all gaps and providing a remediation plan with assigned responsibilities and timelines. This analysis prevents submission rejection and reduces total registration time.
A detailed compliance roadmap covering all post-registration obligations under Colombian law, including post-market surveillance requirements under Resolution 4816 of 2008, registration renewal timelines, and mandatory incident reporting procedures.
A vetted local legal representative identification report, a template representation agreement compliant with Colombian commercial law, and all INVIMA authorization documentation required to establish the representative relationship for your registration.
A complete record of all INVIMA submission activities including SIREM filing confirmations, official correspondence, query responses, and review status updates, providing a full audit trail of the registration process.
A targeted market intelligence brief covering the Colombian medical devices competitive landscape, key hospital and clinic procurement networks, public sector purchasing channels through SECCOP, and priority distribution partner profiles for your device category.
A structured handover package delivered upon certificate issuance, including the authenticated INVIMA registration certificate, a labeling compliance checklist for Colombian market packaging, and a post-registration compliance calendar with all key renewal and reporting dates.
Your device is approved in the US or EU and you are ready to expand into Latin America. Colombia is your priority market, but you have no local presence, no established regulatory contacts, and limited familiarity with INVIMA's requirements and processes. You need a partner who can manage the entire registration from classification through certificate issuance while you focus on your commercial strategy.
Whether you are entering Colombia for the first time or resolving a registration challenge, Taevas Global delivers the regulatory expertise and local market knowledge to get your medical device approved and commercially ready. Let us build your path to INVIMA registration today.